Bitao Bu

Tongji Hospital — China

Medicine · Health Sciences

20h-index1.4kcitations72works9.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myasthenia Gravis and Thymoma(35), Peripheral Neuropathies and Disorders(23), Parkinson's Disease and Spinal Disorders(13), Multiple Sclerosis Research Studies(8), Antifungal resistance and susceptibility(7)

Publications72 total

Sleep disturbances in patients with myasthenia gravis: A cross-sectional study
Neurología·2025· 1 citedOpen Access
The pathogenesis of immune-mediated necrotizing myopathy: Progress and therapeutic implications
Biomedicine & Pharmacotherapy·2025· 4 citedOpen Access
The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis
Cellular Immunology·2025· 2 citedOpen Access
The <scp>JAK1</scp>/3 Inhibitor Tofacitinib Regulates Th Cell Profiles and Humoral Immune Responses in Myasthenia Gravis
Muscle & Nerve·2025· 5 cited
Amyloid myopathy mimicked with idiopathic inflammatory myopathy diagnosed using Congo red staining: a case report
BMC Neurology·2024· 2 citedOpen Access
547P The diagnostic value of serum periostin for myocardial involvement in immune-mediated necrotizing myopathy
Neuromuscular Disorders·2024
548P A role of heparin-binding epidermal growth factor-like growth factor in myocardial involvement in immune-mediated necrotizing myopathy
Neuromuscular Disorders·2024
Novel variants and genotype-phenotype correlation in a multicentre cohort of GNE myopathy in China
Journal of Medical Genetics·2024· 7 cited
Exhausted signature and regulatory network of NK cells in myasthenia gravis
Frontiers in Immunology·2024· 4 citedOpen Access
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients
Journal of Inflammation Research·2024· 1 citedOpen Access
Batoclimab vs Placebo for Generalized Myasthenia Gravis
JAMA Neurology·2024· 33 citedOpen Access
Therapeutic potential of natural killer cells in neuroimmunological diseases
Biomedicine & Pharmacotherapy·2024· 10 citedOpen Access
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
EMBO Molecular Medicine·2024· 57 citedOpen Access
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study
Chinese Medical Journal·2024· 2 citedOpen Access
Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study
Therapeutic Advances in Neurological Disorders·2024· 20 citedOpen Access
Effect of thymectomy on the frequencies of peripheral regulatory B and T lymphocytes in patients with Myasthenia gravis-a pilot study
International Journal of Neuroscience·2023· 3 cited
The JAK1/3 inhibitor tofacitinib regulates Th cell profiles and humoral immune responses in myasthenia gravis
Research Square (Research Square)·2023· 1 citedOpen Access
Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort
Pediatric Neurology·2023· 4 cited
Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis
Frontiers in Immunology·2023· 10 citedOpen Access
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
Signal Transduction and Targeted Therapy·2023· 139 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Zhuajin Bi(14), Mengcui Gui(13), Mengge Yang(11), Suqiong Ji(10), Qing Zhang(10), Huajie Gao(9), Jing Lin(8), Min Zhang(7), Yue Li(7), Yayun Cao(7), Ke Shang(6), Dai‐Shi Tian(5), Wei Wang(4), Meini Zhang(4), Hongyu Zhou(4), Chenchen Liu(4), Huizhen Ge(4), Chuan Qin(3), Jun Xiao(3), Minjie Xie(3)